The PRDX2 gene has been found to be upregulated in several cancers, and most recently, PRDX2 has been included in a 6-gene anti-oxidant signature that effectively predicts the prognosis of patients with kidney cancer [88]. This evidence concerns the gene PRDX2 and kidney cancer.